Diversity was characterized in a broad set of breeding lines and exotic lines representing a standard germplasm panel indicating that G. barbadense is much more diverse than G. hirsutum.
The modular observer is first defined and characterized in a general setting and then, a systematic design method is developed on the basis of exact linearization with eigenvalue assignment.
Since the genes responsible for the majority of natural polymorphism in aliphatic GSL have been well characterized in a laboratory setting, the GSL pathway in Arabidopsis provides a good system for understanding the impact that individual genes might have on fitness in the field (Kliebenstein et al., 2001b; Halkier and Gershenzon, 2006; Hansen et al., 2008).
In addition, since MMR and DSB by HR pathway activities are not characterized in a clinical setting, it is difficult to relate our data to clinical studies assessing the outcome of therapeutics such as cisplatin or 5-fluorouracil, which have potential opposing activities on MMR- and HR-deficient tumors.
Analog computers previously used to solve engineering problems had to be programmed in terms of gain settings and patch panel configurations that could be characterized in an instruction set.
The plasma glucose response to breakfast was characterized in a highly controlled setting, while CGMS was used to characterize postprandial glucose on the controlled diet over 24 h, but in the free-living situation.
A strain carrying a deletion of NCU04731 was previously characterized in a transcription factor deletion strain set collection and was named for having short aerial hyphae (sah- 2) [ 5].
Such a condition is characterized in terms of a set of matrix inequalities that can be easily solved by using the semi-definite programming method.
Therefore, rapamycin, a substance well characterized in the clinical setting, might be an attractive target to treat DKC patients as they harbor increased numbers of senescent cells which contain dysfunctional chromosome ends.
Bortezomib-induced peripheral neuropathy (BiPN) has previously been characterized in the setting of single-agent bortezomib±dexamethasone for relapsed or refractory patients.
